Filing Details
- Accession Number:
- 0001237899-20-000039
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-31 16:37:49
- Reporting Period:
- 2020-08-27
- Accepted Time:
- 2020-08-31 16:37:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1238303 | J Joseph Larosa | 777 Old Saw Mill River Road Tarrytown NY 10591 | Evp General Counsel And Secret | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-08-27 | 6,000 | $52.03 | 20,438 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-08-27 | 3,197 | $614.87 | 17,241 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2020-08-27 | 4,000 | $52.03 | 21,241 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-08-27 | 2,131 | $614.87 | 19,110 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2020-08-31 | 4,672 | $615.04 | 14,438 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-08-27 | 6,000 | $0.00 | 6,000 | $52.03 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-08-27 | 4,000 | $0.00 | 4,000 | $52.03 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,000 | 2021-12-16 | No | 4 | M | Direct | |
| 0 | 2021-12-16 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 287 | Indirect | By 401(k) Plan |
Footnotes
- Represents volume-weighted average price of sales of 4,672 shares of Company stock on August 31, 2020 at prices ranging from $615.00 to $615.40. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 31, 2020 at each separate price.
- With respect to 6,000 underlying shares (of which 0 remain outstanding), the option became exercisable on December 31, 2014, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2014. With respect to 4,000 underlying shares (of which 0 remain outstanding), the stock option award vested in four equal annual installments, commencing one year after the date of grant.
Billionaire Hedge Funds
